Floatz logo

117 assets in Colorectal Neoplasm

Therapeutic assets addressing Colorectal Neoplasm, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
ly4257496
Colorectal Neoplasm
Eli Lilly and CompanyP1C (39)
ly4337713
Colorectal Neoplasm
Eli Lilly and CompanyP1C (39)
Metarrestin
Colorectal Neoplasm
National Cancer Institute (NCI)P1C (39)
Osimertinib
Colorectal Neoplasm
AstraZenecaP1C (39)
pf-07934040
Colorectal Neoplasm
PfizerP1C (39)
pf-07985045
Colorectal Neoplasm
PfizerP1C (39)
pf-08046049
Colorectal Neoplasm
Seagen, a wholly owned subsidiary of PfizerP1C (39)
pf-08046050
Colorectal Neoplasm
Seagen, a wholly owned subsidiary of PfizerP1C (39)
pf-08046052
Colorectal Neoplasm
Seagen, a wholly owned subsidiary of PfizerP1C (39)
pf-08052666
Colorectal Neoplasm
Seagen, a wholly owned subsidiary of PfizerP1C (39)
Desflurane
Colorectal Neoplasm
Tam Anh Research InstituteN/AD (30)
Dexmedetomidine
Colorectal Neoplasm
Tam Anh Research InstituteN/AD (30)
Ons_211567
Colorectal Neoplasm
Daesang WellifeN/AD (30)
Sasanlimab
Colorectal Neoplasm
PfizerP1D (28)
afm24
Colorectal Neoplasm
NKGen Biotech, Inc.P1/2D (26)
Showing 101 to 117 of 117 assets
PreviousPage 3 of 3Next